MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features
<p>Abstract</p> <p>Background</p> <p>MicroRNA (miRNA) expression is known to be deregulated in ovarian carcinomas. However, limited data is available about the miRNA expression pattern for the benign or borderline ovarian tumors as well as differential miRNA expression...
Main Authors: | Lee Heejeong, Park Chul, Deftereos Georgios, Morihara Janice, Stern Joshua E, Hawes Stephen E, Swisher Elizabeth, Kiviat Nancy B, Feng Qinghua |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-08-01
|
Series: | World Journal of Surgical Oncology |
Subjects: | |
Online Access: | http://www.wjso.com/content/10/1/174 |
Similar Items
-
Anti-HER2/neu Antibody Reduces Chemotherapy-Induced Ovarian Toxicity—From Bench to Bedside
by: Mattan Levi, et al.
Published: (2020-12-01) -
The expression of immunohistochemical markers estrogen receptor, progesterone receptor, Her-2-neu, p53 and Ki-67 in epithelial ovarian tumors and its correlation with clinicopathologic variables
by: Mary T Sylvia, et al.
Published: (2012-01-01) -
Her-2/neu expression is a negative prognosticator in ovarian cancer cases that do not express the follicle stimulating hormone receptor (FSHR)
by: Heublein Sabine, et al.
Published: (2013-01-01) -
Contribution of Immunohistochemistry in Prognostic Assessment of Epithelial Ovarian Carcinoma – Review of the Literature I.
by: Markéta Tomšová, et al.
Published: (2006-01-01) -
Clinicopathological Features of Triple Negative Breast Carcinoma
by: Gowry Maram Reddy, et al.
Published: (2017-01-01)